Table: Pharmarise Holdings - 9-MTH group results

Pharmarise Holdings

14/04/2021 08:30

Apr 14 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Feb 28, 2021        Feb 29, 2020     May 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               38.46               38.59            51.93    
                   (-0.3 pct)          (+0.2 pct)       (+1.8 pct)  
  Operating          761 mln             765 mln            1.19    
                   (-0.5 pct)         (+172.0 pct)      (+14.8 pct) 
  Recurring          612 mln             747 mln            1.17    
                   (-18.1 pct)        (+241.7 pct)      (+14.6 pct) 
  Net                114 mln             705 mln          378 mln   
                   (-83.8 pct)                          (-34.5 pct) 
  EPS               12.27 yen           74.21 yen        40.62 yen  
  EPS Diluted       9.98 yen            60.00 yen                   
  Ann Div                               14.00 yen        14.00 yen  
  -Q2 div              NIL                 NIL                      
  -Q4 div                               14.00 yen        14.00 yen  
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T